Poster Presentations
(Click on the links under the title to view the presentations and abstracts)
If you would like to contact the author, please download the contact information HERE.
LAST NAME |
FIRST NAME |
TITLE |
ADILI |
ALI |
IL-10 IN TRIPLE NEGATIVE METASTATIC BREAST CANCER |
AGGARWAL |
VAISHALI |
INTERFERON-Γ, A MASTER REGULATOR DRIVING IMMUNE RESPONSE |
AHMED |
AML |
STUDY OF PI3K ONCOGENE ADDICTION IN NON-SMALL CELL LUNG |
BHATIA |
ISHAN |
HELPING TO DEVELOP NOVEL CAR-T CELL THERAPY FOR PEDIATRIC ACUTE |
CHAKRABORTY |
SRIJA |
ENHANCING NATURAL KILLER CELL HOMING TO MELANOMA ORGANOIDS |
CHEN |
YU-HIS |
TITERING CAR EXPRESSION ON PRIMARY T CELLS ENABLED BY MICROFLUIDIC |
CHOUKRANI |
GHIZLANE |
GALECTIN-9 SHIFTS THE PHAGOCYTIC BALANCE ON CANCER CELLS AND TRIGGERS |
CHUKWUKERE |
CHINAZAEKPERE |
IMMUNOTHERAPY - PINEAPPLE, AND COLOSTRUM FROM BREASTMILK CAN |
DAR |
MUKHTAR AHMAD |
DESIGNING OF PEPTIDE BASED MULTI-EPITOPE VACCINE CONSTRUCT AGAINST |
GUNTURI |
ALEKHYA |
CHARACTERIZATION OF NOVEL ANTI-TIGIT ANTIBODIES FOR POTENTIAL ANTI-TUMOR |
HAGAR |
AMIT |
AN INTEGRATED VIRTUAL TISSUE PLATFORM FOR INCORPORATING EXERCISE ONCOLOGY |
HUANG |
YUE |
MESOPOROUS SILICA NANOPARTICLES AS ROS SENSITIVE CARRIER FOR THERAVAC |
JALBUENA |
AMANGELIN |
DEFINING T-CELL RESPONSES TO MUTANT AND NON-MUTANT ANTIGENS IN |
KARALIOTA |
SEVASTI |
HETERODIMERIC IL-15 (HETIL-15) IMMUNOTHERAPY REVERSES CD8+T CELL METABOLIC |
KNIGHT |
JULIA |
ALDH INHIBITION AS MODULATOR OF OVARIAN TUMOR ASSOCIATED MACROPHAGES |
KONDURI |
VANAJA |
DENDRITIC CELL GOVERNANCE OF AN INNATE-LIKE CYTOTOXIC EFFECTOR MEMORY |
LEYFMAN |
YAN |
IMPROVING HEALTHCARE ACCESS THROUGH THE DEVELOPMENT OF AN ONTOLOGY |
LIU |
WENLONG |
ANTI-MESOTHELIN IMMUNOTOXIN LMB-100 INDUCES COMPLETE TUMOR REGRESSIONS |
MAJUMDAR |
SHUBHABRATA |
FINE-TUNING CHIMERIC ANTIGEN RECEPTOR SIGNALING BY REDUCING CD3Ζ ITAM DIVERSITY |
MARLIN ANDREWS |
CELINE |
HARNESSING THE INNATE IMMUNE RESPONSE FOR POTENTIAL MALIGNANT |
MARTIN |
SUNIL |
EXPANSION AND TRANSDUCTION OF HUMAN Γ9Δ2 T CELLS TO TARGET |
MASTROPAOLO |
MARIA |
PATIENT-DERIVED ORGANOIDS MODEL SENSITIVITY AND RESISTANCE TO PARP |
MHIBIK |
MAISSA |
TREATMENT WITH BTK INHIBITOR OR BCL-2 INHIBITOR ENHANCES CYTOTOXICITY OF THE |
MOHANTY |
AYUSHI |
COMBINED DRUG EFFICACY IN PRECLINICAL MODELS OF COLORECTAL CANCER |
MOORE |
EMILY |
PAG Facilitates Immune Synapse Organization and PD-1 Function |
MUELLER |
JUERGEN |
DELETION OF NK CELLS AND RE-DIRECTING OF DENDRITIC CELL DIFFERENTIATION DURING |
NAHAR |
SAIFUN |
EFFECTIVE IMMUNOTHERAPEUTIC REGIMEN WITH COMBINATIONS OF TLR |
NCEMBU |
SIKOZILE |
RECOMBINANT CD-64 DIRECTED SINGLE-CHAIN ANTIBODY FUSION PROTEIN |
NISAR |
ALBEENA |
IMPLEMENTING FAST TRACK COST-EFFECTIVE PROCESS DEVELOPMENTAL |
ONDA |
MASANORI |
15B6 CAR T CELLS THAT BIND TO A JUXTAMEMBRANE REGION OF MESOTHELIN |
OUCHEN |
KHAOULA |
OPTIMIZED LENTIVIRAL VECTOR DESIGN FOR ON-COMMAND GENE-CARGO |
PATKAR |
SUSHANT |
TUMOR MICROENVIRONMENT (TME) LANDSCAPE DICTATES METASTATIC |
PRITAM |
MANISHA |
DEVELOPMENT OF LAG3 IMMUNE CHECKPOINT INHIBITORS FOR CANCER |
SANYAL |
SREYA |
IMMUNOLOGICAL FEATURES AFFECTING GASTRIC TUMOR SENSITIVITY |
SMITH-UFFEN |
MEGAN |
ESTIMATING SCENARIOS FOR SURVIVAL TIME IN PATIENTS WITH |
SMITH-UFFEN |
MEGAN |
IMMUNE CHECKPOINT INHIBITOR-INDUCED POLYARTHRITIS: A CASE SERIES |
STRAVOKEFALOU |
VASILIKI |
REDUCTION OF CIRCULATING TUMOR CELLS AND METASTASIS FORMATION |
UGUZOVA |
SABINE |
PREDICTIVE VALUE OF CT SCANS AT 3 AND 6 MONTHS ON OVERALL SURVIVAL |
VIGANT |
FREDERIC |
IN VIVO GENERATION OF TUMOR-METABOLISM-REGULATED HER-2-SPECIFIC |
VOYNOVA |
ELISAVETA |
INCREASED ACTIVITY OF A NK-SPECIFIC CAR-NK FRAMEWORK TARGETING CD3 AND |
WANG |
BINBIN |
DECOUPLING CYTOTOXIC T LYMPHOCYTE AND EXHAUSTED T LYMPHOCYTE |
WARD |
ROSS |
INFLAMMASONE ACTIVATING NANOPARTICLES PROMOTE |
YOSHIMOTO |
SHO |
PD-1CD28 SWITCH RECEPTOR OVERCOMES PD-L1 MEDIATED |
ZENS |
STEFAN |
CHARTING THE TUMOR-REACTIVE T CELL REPERTOIRE IN DNA DAMAGE |